Search clinical trials for: BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System

Total 390 results

Boston Scientific Corporation

Completed

SYNERGY China: Assess SYNERGY Stent in China

Cardiovascular Diseases

China
B. Braun Melsungen AG
Charite University, Berlin, Germany

Completed

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

Coronary Artery Disease (CAD)

Germany, Spain, Malaysia
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Biotronik AG

Active, not recruiting

First in Men Study: BIOMAG-I

Coronary Artery Disease

Austria, Spain, Belgium, Poland, Sweden, Germany, Netherlands, Switzerland
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
Xijing Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Tang-Du Hospital; General... and other collaborators

Recruiting

HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

ION US Post-Approval Study

Coronary Artery Disease | Atherosclerosis

United States
University Hospital, Toulouse
Boston Scientific Corporation

Completed

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction (COVER-AMI)

Acute Coronary Syndrome

France
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels (PLATINUM SV)

Coronary Artery Disease

United States, Australia, France, Belgium, New Zealand, Japan
Chinese University of Hong Kong

Active, not recruiting

Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period (TQJ230)

Cardiovascular Diseases

Hong Kong
Boston Scientific Corporation

Completed

A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent System

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
Deutsches Herzzentrum Muenchen
Bayerische Forschungsstiftung Muenchen

Completed

Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

Coronary Disease

Germany
MINVASYS

Completed

Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent (BIPAX)

Coronary Disease

Bulgaria, France, Italy, Brazil, Netherlands, Poland, Spain
Sino Medical Sciences Technology Inc.

Completed

First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

Coronary Artery Disease

Netherlands, Belgium, Spain, Portugal
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
Scitech Produtos Medicos Ltda

Completed

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus (INSPIRON)

Coronary Artery Disease

Brazil
University Hospitals, Leicester

Terminated

Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia (TENS-LA)

Skin Graft | Donor Site Complication

United Kingdom
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

Coronary Stenosis

United States
University of Avignon

Completed

Myocardial Function and Vitamin D Supplementation in Diabetes. (VitaDD)

Diabetes Complications | Vitamin D Deficiency | Vitamin D Supplementation | Myocardial Dysfunction

France
Beijing Tiantan Hospital

Recruiting

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial (DREAM-PRIDE)

Stroke | Intracranial Atherosclerotic Disease

China
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
Concept Medical Inc.
Cardiovascular Research Foundation, New York

Not yet recruiting

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels (MAGICAL-SV)

Cardiovascular Diseases | Coronary Artery Disease | Native Coronary Artery Stenosis
Conor Medsystems

Completed

CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation

Coronary Disease

Belgium
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

Coronary Artery Disease

Denmark
Seoul National University Hospital
Boston Scientific Corporation; Abbott

Unknown

Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing (EXCELLENT)

Coronary Artery Disease

Korea, Republic of
Laval University
Boston Scientific Corporation

Completed

Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial (VELETI)

Coronary Artery Bypass Grafting

Canada
Boston Scientific Corporation

Completed

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
ReFlow Medical, Inc.

Not yet recruiting

Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia (DEEPER RCT)

Critical Limb Ischemia
Abbott Medical Devices

Active, not recruiting

XIENCE Skypoint Large Vessel Post Approval Study (SPIRIT XLV PAS)

Coronary Artery Disease

United States, Spain, France
Boston Scientific Corporation

Completed

TAXUS PERSEUS Small Vessel (PERSEUS SV)

Coronary Artery Disease

United States
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation (CONVOY)

Coronary Artery Perforation

China
Assistance Publique - Hôpitaux de Paris

Terminated

Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction (ARCHER)

Heart-lung Transplant Rejection

France
Xijing Hospital
Air Force Military Medical University, China; Chinese Academy of Medical Sciences... and other collaborators

Unknown

Efficacy and Safety of Firebird 2 Stent in Treatment of Complex Coronary Lesions in Diabetes

Coronary Artery Disease

China
Cordis Corporation

Completed

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Coronary Artery Disease

Brazil
University Heart Center Freiburg - Bad Krozingen
Cordis, Johnson&Johnson company

Unknown

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

Coronary Artery Disease

Germany
Fortis Escorts Heart Institute
Boston Scientific Corporation; Max Neeman Medical International Ltd.

Completed

Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics (Tuxedo)

Type 2 Diabetes | Coronary Heart Disease

India
University Hospital Freiburg

Unknown

Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry) (FRIST)

Stent Thrombosis
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
Zheng Liu

Recruiting

Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms

Chronic Sinusitis

China
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Xijing Hospital

Active, not recruiting

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

Coronary Artery Disease | De Novo Stenosis

China
Biosensors Europe SA

Active, not recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Acute Coronary Syndrome | High Bleeding Risk

United States, Canada, France, Italy, United Kingdom, Germany, Denmark
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Boston Scientific Corporation

Active, not recruiting

PROMUS PREMIER™ China Post-Approval Study

Coronary Artery Disease

China
Azienda Ospedaliera San Camillo Forlanini

Unknown

FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. (FIT)

Myocardial Infarction | Ischemia | Necrosis | Heart Failure | Stents

Italy
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
Biotyx Medical (Shenzhen) Co., Ltd.
VascuScience GmbH; Mediolanum Cardio Research Srl; Euroimage Research Srl

Recruiting

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Critical Limb Ischemia | Infrapopliteal Lesions

Italy
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Infraredx

Terminated

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow (CANARY)

Myocardial Infarction | Coronary Atherosclerosis | Coronary Plaque Embolization

United States

Search clinical trials for: BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations